11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
(
- Contribution to journal › Article
- 2014
-
Mark
The amyloid-β degradation pattern in plasma: A possible tool for clinical trials in Alzheimer's disease
(
- Contribution to journal › Article
- 2013
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
2013) Endokrindagarna, 2013(
- Contribution to conference › Poster
-
Mark
The ELISA-Measured Increase in Cerebrospinal Fluid Tau that Discriminates Alzheimer's Disease from other Neurodegenerative Disorders is not Attributable to Differential Recognition of Tau Assembly Forms
(
- Contribution to journal › Article
- 2012
-
Mark
The determination of aggregated tau in solution and its potential as a tool for the diagnosis of tauopathies
2012) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) In European Journal of Neurology 19(Suppl. 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
Age and diagnostic performance of Alzheimer disease CSF biomarkers
(
- Contribution to journal › Article
- 2011
-
Mark
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.
(
- Contribution to journal › Article
-
Mark
Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
(
- Contribution to journal › Article